Ab&B Bio Tech Co Ltd JS (2627.HK) Stock Price

Ab&B Bio Tech Co Ltd JS Price

CLOSED
25.07
​
Market closed

Ab&B Bio Tech Co Ltd JS's net margin stands at -115.2%, up from -1,008.7% several years earlier.

Ab&B Bio Tech Co Ltd JS stock price

Access this data via the Eulerpool API

Ab&B Bio Tech Co Ltd JS business model & stock analysis

Ab&B Bio Tech Co Ltd JS is a CN-based company operating in Biotechnology industry. The company is headquartered in Taizhou, Jiangsu. The company went IPO on 2025-08-08. Ab&B Bio Tech Co Ltd JS is a China-based company primarily engaged in the research, development, manufacturing, and commercialization of vaccines. Its product pipeline includes two core products, the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, along with 11 other vaccine candidates. The firm primarily operates within the domestic market.

Frequently asked questions about Ab&B Bio Tech Co Ltd JS

Converted at the current exchange rate, the Ab&B Bio Tech Co Ltd JS share trades at 3.34 EUR (25.07 CNY).

The revenue cannot currently be calculated for Ab&B Bio Tech Co Ltd JS.

The profit cannot currently be calculated for Ab&B Bio Tech Co Ltd JS.

The P/E ratio cannot be calculated for Ab&B Bio Tech Co Ltd JS at the moment.

The P/S cannot be calculated for Ab&B Bio Tech Co Ltd JS currently.

The Eulerpool Quality Score for Ab&B Bio Tech Co Ltd JS is 2/10.

The ISIN of Ab&B Bio Tech Co Ltd JS is CNE1000071P9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ab&B Bio Tech Co Ltd JS is 2627.HK. The ticker symbol is used to trade Ab&B Bio Tech Co Ltd JS shares on the stock exchange.

Fair ValueTerminal
24.82 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website abbbio.com
Country
Currency
CNY
Initial public offering
Aug 8, 2025
ISIN
CNE1000071P9
Cusip
Y005PZ107
Market capitalization
9.86 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
—
P/Se
—
EV/EBIT
—
P/B Ratio
67.29
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-25.73 %
Last updated Oct 8, 2026, 6:08 PM

Ab&B Bio Tech Co Ltd JS Peer Group